Jared C. Foster

Subgroup identification from randomized clinical trial data

Jared C. Foster, Jeremy M. G. Taylor, Stephen J. Ruberg · Statistics in Medicine · 2011 · 569 citations · Full text

Public Health, Biostatistics, Clinical Epidemiology +16

Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases

Andrew L. Himelstein, Jared C. Foster, James Khatcheressian et al. · JAMA · 2017 · 357 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Updated Standardized Definitions for Efficacy End Points (STEEP) in Adjuvant Breast Cancer Clinical Trials: STEEP Version 2.0

Sara M. Tolaney, Elizabeth Garrett‐Mayer, Julia White et al. · Journal of Clinical Oncology · 2021 · 221 citations · Full text

Medicine, Biostatistics, Oncology +13

Atezolizumab for Advanced Alveolar Soft Part Sarcoma

Alice P. Chen, Elad Sharon, Geraldine O’Sullivan Coyne et al. · New England Journal of Medicine · 2023 · 152 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP

Jennifer K. Litton, Meredith M. Regan, Lajos Pusztai et al. · Journal of Clinical Oncology · 2023 · 100 citations · Full text

Medicine, Oncology, Breast Oncology +16